NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/12/2024
Back to search
Official data from USPTO
SPHEREMAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
12/12/2024
Classification
Registered
Trademark type
Word
Nice classes
1, 5
Filing date
01/19/2016
Registration date
05/23/2017
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/08/2023
Last transaction
12/08/2023
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
JP
Examiner
POLZER, NATALIE
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
N. C. (pessoa física)
Nissan Chemical Industries, Ltd.
Representatives
James A. Oliff Oliff PLC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and sciencenamely chemical media additives; chemical preparations for use in industrynamely chemical media additives; chemical preparations for scientific purposesnamely chemical media additives; chemical media additivesother than for medical or veterinary purposes; chemical media additives in kit formother than for medical or veterinary purposes; chemical media additives for scientific or research purposesother than for medical or veterinary purposes; chemical media additives in kit form for scientific or research purposesother than for medical or veterinary purposes; chemical media additives for cell cultureother than for medical or veterinary purposes; chemical media additives for tissue cultureother than for medical or veterinary purposes; chemical media additives for culture of microorganismsother than for medical or veterinary purposes; media for cell culture for scientific or research purposesother than for medical or veterinary purposes; media for tissue culture for scientific or research purposesother than for medical or veterinary purposes; media for culture of microorganisms for scientific or research purposesother than for medical or veterinary purposes; media for three-dimensional cell culture for scientific or research purposesother than for medical or veterinary purposes; media for three-dimensional tissue culture for scientific or research purposesother than for medical or veterinary purposes; media for three-dimensional culture of microorganisms for scientific or research purposesother than for medical or veterinary purposes; media for cell culturing for laboratory use; dispersing agents; chemical media additives for use in separation of cellsother than for medical or veterinary purposes; media for cell culture in kit form for scientific or research purposesother than for medical or veterinary purposes; media for tissue culture in kit form for scientific or research purposesother than for medical or veterinary purposes; media for culture of microorganisms in kit form for scientific or research purposesother than for medical or veterinary purposes; all of the above not including reagents and diagnostic materials
Class 5
Pharmaceutical preparations for use in regenerative medicineoncology and hematology; pharmaceutical preparations for the treatment of viral and infectious diseasesautoimmune diseaseskidney diseaseshepatic diseasesneurological diseases and bone diseases; chemical media additives for medical or veterinary purposes; chemical media additives in kit form for medical or veterinary purposes; chemical media additives for cell culturefor medical or veterinary purposes; chemical media additives for tissue culturefor medical or veterinary purposes; chemical media additives for culture of microorganismsfor medical or veterinary purposes; culture media for use in regenerative medicineoncologyhepatology and hematology; culture media for augmentation of bone and other tissues for medical purpose using iPS/ES cells and other stem cells; culture media for use to produce biomedicinein particular antibody medicines and vaccine medicines; culture media of microorganisms for medical use; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; all of the above not including reagents and diagnostic materials
Publications
History of USPTO decisions and trademark events.
35 publications found
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
09/08/2024
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/20/2024
INPC
INVALIDATION PROCESSED
08/20/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/09/2024
C71T
CANCELLED SECTION 71
12/08/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/23/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/13/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/20/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/25/2017
FIMP
FINAL DISPOSITION PROCESSED
08/25/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/23/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
05/23/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/07/2017
PUBO
PUBLISHED FOR OPPOSITION
03/07/2017
GPNX
NOTIFICATION PROCESSED BY IB
03/03/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/15/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/15/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/15/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/19/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/19/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/19/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/19/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/19/2017
RFNT
REFUSAL PROCESSED BY IB
08/05/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/19/2016
RFRR
REFUSAL PROCESSED BY MPU
07/19/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/19/2016
MAFR
APPLICATION FILING RECEIPT MAILED
07/19/2016
CNRT
NON-FINAL ACTION WRITTEN
07/17/2016
DOCK
ASSIGNED TO EXAMINER
07/15/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/15/2016
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/14/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/14/2016
Continuous trademark protection
Get notified about every new filing that threatens SPHEREMAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.